SYN023, a novel humanized monoclonal antibody cocktail, for post-exposure prophylaxis of rabies.
Rabies is a neglected zoonotic disease that is preventable in humans by appropriate post-exposure prophylaxis (PEP). However, current PEP relies on polyclonal immune globulin products purified from pooled human (HRIG) or equine (ERIG) plasma that are either in chronic shortage or in association with...
Main Authors: | Tzu-Yuan Chao, Shiqi Ren, Enyun Shen, Susan Moore, Shou-Feng Zhang, Li Chen, Charles E Rupprecht, Eric Tsao |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-12-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC5754141?pdf=render |
Similar Items
-
In Vivo Efficacy of SYN023, an Anti-Rabies Monoclonal Antibody Cocktail, in Post-Exposure Prophylaxis Animal Models
by: Tzu-Yuan Chao, et al.
Published: (2020-02-01) -
Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans.
by: Thomas Müller, et al.
Published: (2009-01-01) -
Correction: Development of a Mouse Monoclonal Antibody Cocktail for Post-exposure Rabies Prophylaxis in Humans
by: Thomas Müller, et al.
Published: (2009-11-01) -
Correction: Development of a Mouse Monoclonal Antibody Cocktail for Post-exposure Rabies Prophylaxis in Humans.
by: Thomas Müller, et al.
Published: (2009-11-01) -
Rabies antibody levels in pregnant women and their newborns after rabies post-exposure prophylaxis
by: Ahmad Fayaz, et al.
Published: (2012-01-01)